Braidwell LP Ironwood Pharmaceuticals Inc Transaction History
Braidwell LP
- $1.79 Billion
- Q4 2024
A detailed history of Braidwell LP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Braidwell LP holds 5,440,277 shares of IRWD stock, worth $10.4 Million. This represents 1.35% of its overall portfolio holdings.
Number of Shares
5,440,277
Previous 4,438,232
22.58%
Holding current value
$10.4 Million
Previous $18.3 Billion
99.87%
% of portfolio
1.35%
Previous 0.52%
Shares
4 transactions
Others Institutions Holding IRWD
# of Institutions
242Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$43.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$37.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$31.5 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$22.5 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$18.2 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $294M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...